• 1

Find the latest funding information here.

  • 25/02/2020

    NEW

    Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP® for Complicated Urinary Tract Infections
    Download PDF
  • 03/09/2019
    Allecra Therapeutics to Present Data at ASM/ESCMID 2019 Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Download PDF
  • 22/08/2018
    Allecra Therapeutics successfully enters next development phase
    Download PDF
  • 17/04/2018
    Allecra Therapeutics to present data at 28th European Congress of Clinical Microbiology and Infectious Diseases
    Download PDF
  • 26/03/2018
    Allecra Therapeutics announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, Enmetazobactam, in Combination with Cefepime to treat complicated Urinary Tract Infections (cUTI)
    Download PDF
  • 03/04/2018
    Allecra Therapeutics announces participation at the H.C. Wainwright annual global life sciences conference in Monte Carlo, Monaco on April 8-10,2018
    Download PDF
  • 04/05/2017
    Allecra Therapeutics Strengthens Leadership Team with Appointment of New Chairman and Chief Medical Officer
    Download PDF
  • 4/12/2017
    Allecra Therapeutics Announces New Staged Financing Deal to Take the Company Through to End of Phase 3
    Download PDF
  • 06/04/2016
    Allecra Therapeutics Announces €22 Million Series B Financing
    Download PDF
  • 1

Scientific Information

Journal Publications

 

Conference Poster  


Contact

Allecra Therapeutics GmbH
Im Kränzliacker 9
79576 Weil am Rhein
Germany
 

 

Allecra Therapeutics SAS
10 rue Alexandre Freund
68300 Saint-Louis France
Tel +33 3 8968 9876

Mail

IR@allecra.com
If you have any questions about our work,
please feel free to contact us.

All rights reserved
Copyright 2018
Allecra Therapeutics SAS